reshetylova doesn't know what he/she is talking about. There is no redo. Also, INNV would have had to disclose that. If they didn't, they would have a number of law suites against them.
However, stock will continue to drop. I don't see anything that can change that at this time. If Fluticare approval doesn't come this quarter, look for 0.05-0.10. Not a stock worth buying at this time. Put your money in a know item (bank stocks).
Also, if Fluticare approval does come, how many more shares will they have to float?
They are trying to avoid debt with dilution. But that will keep the stock well below 1.00 or even 0.50 this year.
Again, I reiterate RS by the company. They will have no choice. At the current price, a significantly greater number of shares will have to be offered up to get more money.
I'm sure the market knows that and therefore the perception of INNV will continue to suck.
News 
Market Data 
Discover 
AI
